Work

Breast density and metabolic factors in DCIS: systematic review and meta-analysis

Year: 2026
Type: article
Abstract: Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive breast cancer, yet factors associated with DCIS initiation, progression to invasive breast cancer, and recurrence of ipsilateral DCIS or invasive breast cancer following treatment remain poorly understood. Understanding how systemic and local microenvironment-related factors influence DCIS biology may improve risk stratification and help to distinguish lesions likely to remain indolent from those at high risk of progressing to invasive breast cancer. We conducted a systematic review and meta-analysis to evaluate associations between breast density, metabolic risk factors, adipocyte-related measures, and background parenchymal enhancement (BPE) with DCIS outcomes. A systematic search identified 35 eligible studies comprising 47,796 new DCIS diagnoses or ipsilateral invasive breast cancer (iIBC) diagnoses. Higher mammographic breast density was consistently associated with increased risk of DCIS initiation across menopausal subgroups (pooled relative effect 2.36; 95% CI 1.79–3.11), with supporting studies generally at low risk of bias. Higher BMI was associated with lower risk of DCIS initiation in premenopausal women (0.74; 95% CI 0.63–0.87) where an opposite but non-significant association was observed in postmenopausal women (1.17; 95% CI 0.99–1.37). Evidence regarding adipocyte-related measures, metabolic risk factors beyond BMI, and recurrence outcomes was limited and heterogeneous. No eligible studies evaluated progression to invasive breast cancer after untreated DCIS. These findings support a role for breast density and adiposity-related factors in early DCIS development. Whereas DCIS initiation has been relatively well-described, evidence regarding progression and recurrence remains sparse, highlighting a critical research gap in improving biologically informed risk stratification in DCIS.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $4,190
OpenAlex ID: W7228874875
FWCI:
Cites:
Cited by:
Related to: 10